Letter: Hyperactivity after a sulphonamide.
D001008:Anxiety Disorders / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations / Q000009:adverse effects; D005260:Female; D006801:Humans; D008875:Middle Aged; D013411:Sulfadiazine / Q000008:administration & dosage / Q000009:adverse effects*; D013416:Sulfamerazine / Q000008:administration & dosage / Q000009:adverse effects*; D013432:Sulfathiazoles / Q000008:administration & dosage / Q000009:adverse effects*; D013607:Tablets / Q000009:adverse effects
D004338:Drug Combinations; D013432:Sulfathiazoles; D013607:Tablets; D013411:Sulfadiazine; D013416:Sulfamerazine